Exclusive

Publication

Byline

Location

US Patent Issued to The Johns Hopkins University, Lieber Institute on June 23 for "Compounds which inhibit RNA polymerase" (American, Finnish Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,482, issued on June 23, was assigned to The Johns Hopkins University (Baltimore) and Lieber Institute Inc. (Baltimore). "Compounds which in... Read More


US Patent Issued to Eli Lilly and Co. on June 23 for "Cocrystalline forms of FGFR3 inhibitors" (Indiana Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,483, issued on June 23, was assigned to Eli Lilly and Co. (Indianapolis). "Cocrystalline forms of FGFR3 inhibitors" was invented by David A... Read More


US Patent Issued to Shenzhen TargetRx on June 23 for "Substituted piperidines as bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,484, issued on June 23, was assigned to Shenzhen TargetRx Inc. (Shenzhen, China). "Substituted piperidines as bruton's tyrosine kinase inhi... Read More


US Patent Issued to AUGUSTA UNIVERSITY RESEARCH INSTITUTE on June 23 for "Substituted pyrazolo[4,3-Dpyrimidines as gut-targeted phosphodiesterase inhibitors" (Georgia Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,485, issued on June 23, was assigned to AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC. (Augusta, Ga.). "Substituted pyrazolo[4,3-Dpyrimidines a... Read More


US Patent Issued to ASSIA CHEMICAL INDUSTRIES on June 23 for "Solid state forms of AT-001 and process for preparation thereof" (Indian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,486, issued on June 23, was assigned to ASSIA CHEMICAL INDUSTRIES LTD. (Tel Aviv, Israel). "Solid state forms of AT-001 and process for pre... Read More


US Patent Issued to SANOFI on June 23 for "Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" (French Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,487, issued on June 23, was assigned to SANOFI (Paris). "Imidazo[1,2-b[1,2,4triazol derivatives for use in therapy" was invented by Antonio... Read More


US Patent Issued to C4 Therapeutics on June 23 for "Spirocyclic compounds" (Swiss, American, French Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,488, issued on June 23, was assigned to C4 Therapeutics Inc. (Watertown, Mass.). "Spirocyclic compounds" was invented by Christopher G. Nas... Read More


US Patent Issued to Sitryx Therapeutics on June 23 for "Compounds" (British Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,489, issued on June 23, was assigned to Sitryx Therapeutics Ltd. (Oxford, Great Britain). "Compounds" was invented by Alessandro Mazzacani ... Read More


US Patent Issued to Hoffmann-La Roche on June 23 for "Heterocyclic compounds" (Swiss, French, German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,490, issued on June 23, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Heterocyclic compounds" was invented by Carsten Kroll... Read More


US Patent Issued to Redona Therapeutics on June 23 for "Compounds targeting RNA-binding proteins or RNA-modifying proteins" (Massachusetts Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,491, issued on June 23, was assigned to Redona Therapeutics Inc. (Watertown, Mass.). "Compounds targeting RNA-binding proteins or RNA-modif... Read More